-
Something wrong with this record ?
Defective viral genomes from chikungunya virus are broad-spectrum antivirals and prevent virus dissemination in mosquitoes
LI. Levi, VV. Rezelj, A. Henrion-Lacritick, D. Erazo, J. Boussier, T. Vallet, V. Bernhauerová, Y. Suzuki, L. Carrau, J. Weger-Lucarelli, MC. Saleh, M. Vignuzzi
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
NLK
Directory of Open Access Journals
from 2005
Free Medical Journals
from 2005
Public Library of Science (PLoS)
from 2005
PubMed Central
from 2005
Europe PubMed Central
from 2005
ProQuest Central
from 2005-09-01
Open Access Digital Library
from 2005-01-01
Open Access Digital Library
from 2005-01-01
Open Access Digital Library
from 2005-09-01
Medline Complete (EBSCOhost)
from 2005-09-01
Health & Medicine (ProQuest)
from 2005-09-01
- MeSH
- Aedes virology MeSH
- Antiviral Agents pharmacology MeSH
- Defective Viruses genetics MeSH
- Genome, Viral * MeSH
- Chikungunya Fever immunology transmission virology MeSH
- Mosquito Vectors virology MeSH
- Humans MeSH
- Virus Replication * MeSH
- Chikungunya virus genetics growth & development isolation & purification MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Research Support, U.S. Gov't, Non-P.H.S. MeSH
Defective viral genomes (DVGs) are truncated and/or rearranged viral genomes produced during virus replication. Described in many RNA virus families, some of them have interfering activity on their parental virus and/or strong immunostimulatory potential, and are being considered in antiviral approaches. Chikungunya virus (CHIKV) is an alphavirus transmitted by Aedes spp. that infected millions of humans in the last 15 years. Here, we describe the DVGs arising during CHIKV infection in vitro in mammalian and mosquito cells, and in vivo in experimentally infected Aedes aegypti mosquitoes. We combined experimental and computational approaches to select DVG candidates most likely to have inhibitory activity and showed that, indeed, they strongly interfere with CHIKV replication both in mammalian and mosquito cells. We further demonstrated that some DVGs present broad-spectrum activity, inhibiting several CHIKV strains and other alphaviruses. Finally, we showed that pre-treating Aedes aegypti with DVGs prevented viral dissemination in vivo.
École doctorale BioSPC Université Paris Diderot Sorbonne Paris Cité Paris France
École doctorale Frontières du vivant Université Paris Diderot Paris France
Institut Pasteur Viral Populations and Pathogenesis Unit CNRS UMR 3569 Paris France
Institut Pasteur Viruses and RNAi Unit CNRS UMR 3569 Paris France
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21019272
- 003
- CZ-PrNML
- 005
- 20210830100842.0
- 007
- ta
- 008
- 210728s2021 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1371/journal.ppat.1009110 $2 doi
- 035 __
- $a (PubMed)33556143
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Levi, Laura I $u Institut Pasteur, Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Paris, France $u École doctorale BioSPC, Université Paris Diderot, Sorbonne Paris Cité, Paris, France
- 245 10
- $a Defective viral genomes from chikungunya virus are broad-spectrum antivirals and prevent virus dissemination in mosquitoes / $c LI. Levi, VV. Rezelj, A. Henrion-Lacritick, D. Erazo, J. Boussier, T. Vallet, V. Bernhauerová, Y. Suzuki, L. Carrau, J. Weger-Lucarelli, MC. Saleh, M. Vignuzzi
- 520 9_
- $a Defective viral genomes (DVGs) are truncated and/or rearranged viral genomes produced during virus replication. Described in many RNA virus families, some of them have interfering activity on their parental virus and/or strong immunostimulatory potential, and are being considered in antiviral approaches. Chikungunya virus (CHIKV) is an alphavirus transmitted by Aedes spp. that infected millions of humans in the last 15 years. Here, we describe the DVGs arising during CHIKV infection in vitro in mammalian and mosquito cells, and in vivo in experimentally infected Aedes aegypti mosquitoes. We combined experimental and computational approaches to select DVG candidates most likely to have inhibitory activity and showed that, indeed, they strongly interfere with CHIKV replication both in mammalian and mosquito cells. We further demonstrated that some DVGs present broad-spectrum activity, inhibiting several CHIKV strains and other alphaviruses. Finally, we showed that pre-treating Aedes aegypti with DVGs prevented viral dissemination in vivo.
- 650 _2
- $a Aedes $x virologie $7 D000330
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antivirové látky $x farmakologie $7 D000998
- 650 _2
- $a horečka chikungunya $x imunologie $x přenos $x virologie $7 D065632
- 650 _2
- $a virus chikungunya $x genetika $x růst a vývoj $x izolace a purifikace $7 D002646
- 650 _2
- $a defektní viry $x genetika $7 D003673
- 650 12
- $a genom virový $7 D016679
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a komáří přenašeči $x virologie $7 D000072138
- 650 12
- $a replikace viru $7 D014779
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a Research Support, U.S. Gov't, Non-P.H.S. $7 D013486
- 700 1_
- $a Rezelj, Veronica V $u Institut Pasteur, Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Paris, France
- 700 1_
- $a Henrion-Lacritick, Annabelle $u Institut Pasteur, Viruses and RNAi Unit, CNRS UMR 3569, Paris, France
- 700 1_
- $a Erazo, Diana $u Institut Pasteur, Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Paris, France
- 700 1_
- $a Boussier, J $u Institut Pasteur, Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Paris, France $u École doctorale Frontières du vivant, Université Paris Diderot, Paris, France
- 700 1_
- $a Vallet, Thomas $u Institut Pasteur, Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Paris, France
- 700 1_
- $a Bernhauerová, Veronika $u Institut Pasteur, Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Paris, France $u Department of Biophysics and Physical Chemistry, Faculty of Pharmacy, Charles University, Hradec Králové, Czech Republic
- 700 1_
- $a Suzuki, Yasutsugu $u Institut Pasteur, Viruses and RNAi Unit, CNRS UMR 3569, Paris, France
- 700 1_
- $a Carrau, Lucia $u Institut Pasteur, Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Paris, France $u École doctorale BioSPC, Université Paris Diderot, Sorbonne Paris Cité, Paris, France
- 700 1_
- $a Weger-Lucarelli, James $u Institut Pasteur, Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Paris, France $u Department of Biomedical Sciences and Pathobiology, Virginia Tech, VA-MD Regional College of Veterinary Medicine, Blacksburg, Virginia, United States of America
- 700 1_
- $a Saleh, Maria-Carla $u Institut Pasteur, Viruses and RNAi Unit, CNRS UMR 3569, Paris, France
- 700 1_
- $a Vignuzzi, Marco $u Institut Pasteur, Viral Populations and Pathogenesis Unit, CNRS UMR 3569, Paris, France
- 773 0_
- $w MED00008922 $t PLoS pathogens $x 1553-7374 $g Roč. 17, č. 2 (2021), s. e1009110
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33556143 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210728 $b ABA008
- 991 __
- $a 20210830100842 $b ABA008
- 999 __
- $a ok $b bmc $g 1690163 $s 1139718
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 17 $c 2 $d e1009110 $e 20210208 $i 1553-7374 $m PLOS pathogens $n PLoS Pathog $x MED00008922
- LZP __
- $a Pubmed-20210728